Business Description
PolyPid Ltd. is an Israeli biopharmaceutical company, founded in 2008 and based in Petah Tikva, that develops medicines designed to be delivered directly to specific areas of the body and released gradually over time. Its most advanced product, D-PLEX100, is currently in a late-stage clinical trial aimed at preventing infections in patients recovering from major abdominal surgery. The company is also working on an early-stage cancer treatment called OncoPLEX and has partnered with ImmunoGenesis Inc. to develop therapies targeting solid tumors.
